SPRY NASDAQ
ARS Pharmaceuticals, Inc.
1W: -0.2%
1M: -30.1%
3M: -51.1%
YTD: -64.6%
1Y: -59.7%
3Y: +11.8%
5Y: -61.6%
$4.07
-0.05 (-1.21%)
Weekly Expected Move ±8.1%
$3
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$117M
Revenue
+4.1% YoY
$-215M
Net Income
-348.7% YoY
$-197M
Free Cash Flow
-268.3% YoY
61.8%
Gross Margin
-182.6%
Op. Margin
-185.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-210.3%
ROA-76.5%
ROIC-424.3%
Valuation
P/E-1.9
P/B32.3
EV/EBITDA-4.0
Leverage
Debt/Equity13.72
Current Ratio3.48
Interest Cov.-42.8x
Quality Scores
Piotroski F2/9
Altman Z-1.92
Beneish M-1.72